Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2000
11/30/2000CA2373643A1 Anti-tumor comprising boroproline compounds
11/30/2000CA2373577A1 .alpha.-amino-.beta.-sulfonyl hydroxamic acid compounds
11/30/2000CA2372887A1 Heterocyclic analgesic compounds and their use
11/30/2000CA2372743A1 New pharmaceutically active compounds
11/30/2000CA2372580A1 Substituted phenyl compounds with immunosuppressing activity and pharmaceutical compositions
11/30/2000CA2372567A1 Indole-type derivatives as inhibitors of p38 kinase
11/30/2000CA2371923A1 Methods for treatment of asthma using s-oxybutynin
11/30/2000CA2371920A1 Niacinamide compositions with reduced tack
11/30/2000CA2371904A1 Inhibitors of factor xa
11/30/2000CA2369933A1 Fap-activated anti-tumor compounds
11/30/2000CA2369746A1 Inhibitors of proton-gated cation channels and their use in the treatment of ischaemic disorders
11/30/2000CA2366408A1 Inhibition of histone deacetylase
11/30/2000CA2363784A1 Method of treatment
11/29/2000EP1055720A2 Compositions for stabilizing oxygen-labile species
11/29/2000EP1055707A1 Autodispersing inverse latex
11/29/2000EP1055685A1 Non-antigenic branched polymer conjugates
11/29/2000EP1055682A1 Novel substances kf-1040 and process for producing the same
11/29/2000EP1055668A1 New 4-arylpiperidine derivatives for the treatment of pruritus
11/29/2000EP1055665A1 3-(3-Hydroxyphenyl)-3-amino-propionamide derivatives
11/29/2000EP1055427A1 Use of primaquine derivatives for the treatment of malaria
11/29/2000EP1055426A1 Dysuria remedies
11/29/2000EP1055408A1 Sorbate preserved compositions, process for their manufacture and their use
11/29/2000EP1054995A1 GABAB-R2a, A 7TM RECEPTOR
11/29/2000EP1054994A2 Fermentative preparation process for cytostatics and crystal forms thereof
11/29/2000EP1054993A1 PROCESS FOR THE OBTAINING OF HMG-CoA REDUCTASE INHIBITORS OF HIGH PURITY
11/29/2000EP1054980A1 HUMAN HEPARANASE POLYPEPTIDE AND cDNA
11/29/2000EP1054979A1 Compositions and methods for sensitizing and inhibiting growth of human tumor cells
11/29/2000EP1054963A1 Sequences of an ih ionic channel and the use thereof
11/29/2000EP1054913A2 Method for the production of polymers from n-vinyl compounds
11/29/2000EP1054894A1 Breast cancer resistance protein (bcrp) and the dna which encodes it
11/29/2000EP1054890A1 Oligodeoxyribonucleotides comprising o6-benzylguanine and their use
11/29/2000EP1054889A1 New oxazolidinones with azol-containing tricycles
11/29/2000EP1054887A1 Bicyclic pyridine and pyrimidine derivatives as neuropeptide y receptor antagonists
11/29/2000EP1054886A1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors, in particular as urokinase inhibitors
11/29/2000EP1054885A2 Benzisoxazole derivatives having d4-antagonistic activity
11/29/2000EP1054884A1 Benzofuran-4-carboxamides and their therapeutic use
11/29/2000EP1054882A1 Condensed heterocyclic system derivatives, preparation, pharmaceutical compositions containing them
11/29/2000EP1054881A1 Novel sulfonamide substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
11/29/2000EP1054878A1 Azulene hydroxamic acid derivatives as metalloprotein inhibitors
11/29/2000EP1054877A1 Novel cyclic sulfonamide derivatives as metalloproteinase inhibitors
11/29/2000EP1054876A1 1,3,4-thiadiazoles derivatives as kyn-oh inhibitors
11/29/2000EP1054874A1 Substituted aminophenyl isoxazoline derivatives useful as antimicrobials
11/29/2000EP1054871A2 Pyrimidines and triazines as integrin antagonists
11/29/2000EP1054870A1 Heterocyclic topoisomerase poisons
11/29/2000EP1054869A1 3,4-dihydroquinoline derivatives as nitrogen monoxide synthase (nos) inhibitors
11/29/2000EP1054868A1 Novel substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia
11/29/2000EP1054867A1 Antivirals
11/29/2000EP1054865A1 Farnesyl transferase inhibitors
11/29/2000EP1054863A2 2-aminoquinoline derivatives having d4-agonistic activity
11/29/2000EP1054861A1 Cytostatic agents
11/29/2000EP1054859A1 Processes and intermediates useful to make antifolates
11/29/2000EP1054858A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted-alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
11/29/2000EP1054857A1 Biaryl-acetic acid derivatives and their use as cox-2 inhibitors
11/29/2000EP1054688A1 Method for selecting tumours expressing hla-g, sensitive to anticancer treatment and uses
11/29/2000EP1054682A2 Use of hyperforin and hyperforin-containing extracts in the treatment and prophylaxis of dementing diseases
11/29/2000EP1054681A1 The use of combinations of active agents consisting of antimicrobially active substances and plant extracts containing terpene in veterinary medicine
11/29/2000EP1054680A1 Composition and method for the treatment of bladder cancer
11/29/2000EP1054679A1 Use of surface active agent for the manufacture of a medicament for treatment of disorders of the middle ear
11/29/2000EP1054678A2 Combination of steroid and polyunsaturated fatty acids for treatment of inflammatory conditions
11/29/2000EP1054677A1 Cosmetic or dermatological use of 7-hydroxylated steroids alone and/or in combination with elastin derived peptides
11/29/2000EP1054676A1 Combination preparation of estrogen and anti-estrogen
11/29/2000EP1054675A1 Regulation of estrus and ovulation in gilts
11/29/2000EP1054674A2 Oral liquid formulations of benzoxazinones hiv reverse transcriptase inhibitors
11/29/2000EP1054673A1 Benzoxazine compounds for enhancing synaptic response
11/29/2000EP1054672A1 Morphine sulphate microgranules, method for making same and pharmaceutical preparations
11/29/2000EP1054671A1 New use for pain management
11/29/2000EP1054670A2 Use of chelating agents in the treatment of atherosclerotic conditions
11/29/2000EP1054669A2 Use of thiadiazolo[4,3-a]pyridine derivatives
11/29/2000EP1054668A1 Use of a glutamate release inhibitor in the treatment of retinal ischemia
11/29/2000EP1054667A1 Bicyclic pyrrole compounds, pharmaceutical compositions containing them and their use as antiinflammatory and immunomodulating agents
11/29/2000EP1054666A1 Liquid pharmaceutical formulation containing zotepine
11/29/2000EP1054665A2 Pharmaceutical composition comprising a combination of metformin and fibrate, and its use for the treatment of hyperglycemia
11/29/2000EP1054664A1 Method for modulating macrophage activation
11/29/2000EP1054663A1 Topiramate and related derivatives for treating schizophrenia
11/29/2000EP1054662A1 Water-soluble eye drop
11/29/2000EP1054633A1 Apparatus and method for inhibiting restenosis by applying ultrasound energy together with drugs
11/29/2000EP1054595A1 Methods and compounds for the genetic treatment of hyperlipidemia
11/29/2000EP1054594A1 Inotropic and diuretic effects of exendin and glp-1
11/29/2000EP1054591A1 Improved extracorporeal methods for enhancing antigen presentation and immune responsiveness
11/29/2000EP1001788A4 Boron carbohydrate complexes and uses thereof
11/29/2000EP0900233B1 Steroid nitrite and nitrate ester derivatives useful as anti-inflammatory drugs
11/29/2000EP0896539B1 Use of optically pure (+) norcisapride for treating emesis and central nervous system disorders
11/29/2000EP0863905B1 imidazole lipoxygenase inhibitors
11/29/2000EP0862453A4 Bone morphogenetic protein and fibroblast growth factor compositions and methods for the induction of cardiogenesis
11/29/2000EP0655055B1 Tachykinin antagonists
11/29/2000CN1275129A Oligosaccharide derivatives and process for producing the same
11/29/2000CN1275128A Pyrazolo (3,4-D) pyrimidines with anticonvulsive and antialiergic/antiasthmatic action
11/29/2000CN1275127A Benzimidazole compounds, pharmaceutical compositions containing the compounds and their use
11/29/2000CN1275124A Phthalazine derivatives and remedies for erectile dysfunction
11/29/2000CN1275123A Prostaglandin agonists and their use to treat bone disorders
11/29/2000CN1275082A Solid oral dosage form comprising combination of metformin and glibenclamide
11/29/2000CN1275081A Aqueous liquid preparations
11/29/2000CN1275080A Method of preventing nephrotoxicity caused by cyclosporins and tacrolimus
11/29/2000CN1275079A Stabilized compositions containing benzimidzole-type compounds
11/29/2000CN1275078A Use of 11-(3-dimethylaminoprpylidene)-6,11-dihydrodibenz [b,e] oxepin-2-acetic acid for manufacture of medicament for treating non-allergic ophthalmic inflammatory disorders
11/29/2000CN1275076A Method of administering liposomal encapsulated taxane
11/29/2000CN1275052A Method for preparing substituted 4-phenyl-4-cyanocyclohexanoic acids
11/29/2000CN1274724A Prepn. of 8-cyclopentyl-6-ethyl-3-[substituted]-5,8-dihydro-4H-1,2,3A,7,8-pentaaza-asymmetric indacene
11/29/2000CN1274723A Dicyclic compound, medicine composition containing the same and use thereof
11/29/2000CN1274722A Compound capable of inhibiting thrombocyte agglutination and resisting thrombosis and its preparation and application
1 ... 6201 6202 6203 6204 6205 6206 6207 6208 6209 6210 6211 6212 6213 6214 6215 6216 6217 6218 6219 6220 6221 ... 7860